Related Experiment Video
Updated: Jan 28, 2026

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
Statins and Abnormal Liver Enzymes
Anup Shrestha1,2, Alex Mulmi3,4, Raiko Munankarmi4
1Internal Medicine Residency Program, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Insights
Statins effectively reduce mortality in cardiovascular diseases but can transiently elevate liver enzymes. This review guides physicians on safely using statins in patients with baseline or treatment-induced liver enzyme elevations.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Statins are crucial for managing ischemic heart disease, stroke, and peripheral vascular disease, significantly reducing mortality and morbidity.
- Transient elevations in liver enzymes are a known side effect of statin therapy.
- Physicians face challenges prescribing statins to patients with pre-existing or statin-induced liver enzyme abnormalities.
Purpose of the Study:
- To review current literature and provide guidance on the safe and effective use of statins.
- To address the clinical dilemma of statin prescription in patients with elevated liver enzymes.
Main Methods:
- Literature review of existing studies and clinical guidelines.
- Analysis of data regarding statin efficacy and safety in patients with liver enzyme alterations.
Main Results:
- Statins are generally safe and effective even with mild liver enzyme elevations.
- Premature cessation of statins due to transient enzyme increases can be detrimental.
- Clear guidelines exist for monitoring and managing liver enzymes during statin therapy.
Conclusions:
- Physicians should not prematurely discontinue statins solely based on transient liver enzyme elevations.
- Careful patient selection and monitoring allow for the continued use of statins in most patients with elevated liver enzymes.
- This review aims to support informed clinical decision-making regarding statin therapy.
Abstract:
Statins are a group of essential medications used in ischemic heart disease, stroke, and peripheral vascular disease. In patients with these medical conditions, they have been proven to decrease mortality and morbidity. However, statins can cause transient elevation of liver enzymes in some patients, which has led to the unnecessary cessation of these agents prematurely. Physicians also face a dilemma when determining if they should utilize statins in patients whose liver enzymes are elevated at baseline. This dilemma may prevent physicians from prescribing statins when clinically indicated, and safe. The purpose of this article is to review existing literature that provides guidance on the utilization of statins in clinical scenarios where liver enzymes are elevated at baseline or when liver enzymes increase after the initiation of statin-based therapy.
More Related Videos
12:35In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Published on: November 10, 2011
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
Abnormal Proliferation
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection